Form 8-K - Current report:
SEC Accession No. 0001104659-17-036173
Filing Date
2017-05-30
Accepted
2017-05-30 16:19:32
Documents
2
Period of Report
2017-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-14414_18k.htm 8-K 34418
2 EX-99.1 a17-14414_1ex99d1.htm EX-99.1 13979
  Complete submission text file 0001104659-17-036173.txt   49690
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 17877637
SIC: 2834 Pharmaceutical Preparations